UNSW Sydney’s CHeBA reviews advances in brain imaging and biomarkers for dementia research
Updated
Updated · UNSW Sydney · Apr 18
UNSW Sydney’s CHeBA reviews advances in brain imaging and biomarkers for dementia research
4 articles · Updated · UNSW Sydney · Apr 18
The Lancet Neurology review, led by CHeBA and NeuRA, details how new neuroimaging and blood-based biomarkers enable real-time study of cognitive resilience in living people worldwide.
Researchers can now track how some individuals maintain cognitive function despite significant brain disease, with implications for dementia prevention, especially in low- and middle-income countries where vascular disease is a major factor.
The review calls for standardised measurement, consistent definitions, and greater inclusion of diverse populations to translate cognitive resilience research into effective, equitable dementia prevention strategies globally.
Does our focus on 'resilience' ignore the societal causes of brain decline?
New blood tests predict Alzheimer's decades early. Should everyone get screened?
If a major 2026 trial showed lifestyle changes failed, can we still prevent dementia?
Some brains defy Alzheimer's damage. What is their biological secret?
Could your daily blood pressure reading predict your future dementia risk?
Could fighting poverty be a more effective dementia treatment than any drug?